Insider Trading & Executive Data
Start Free Trial
43 insider trades in the last year. Go beyond summary counts with transaction-level detail, compensation intelligence, and institutional ownership context.
Pennant Group, Inc. is a vertically integrated provider of post-acute care and senior living services operating 123 home health and hospice agencies and 57 senior living communities across 13 states. The business is heavily Medicare/Medicaid-exposed (roughly 48% Medicare, 13% Medicaid) and generated ~75% of 2024 revenue from home health and hospice, with the remainder from senior living. Management runs a decentralized, cluster-based operating model supported by a central Service Center, and pursues organic census growth plus disciplined acquisitions while highlighting data analytics and strong CMS quality scores as competitive advantages. Key operational pressures include labor/wage inflation (payroll ~67.7% of expenses), reimbursement/regulatory changes (PDGM, HHVBP, hospice caps), and integration risk from frequent acquisitions.
Given Pennant’s growth-by-acquisition model and use of non‑GAAP metrics, compensation for executives is likely tied to volume and margin metrics such as admissions, occupancy, revenue per episode/unit, Adjusted EBITDA and Adjusted EBITDAR rather than GAAP net income alone. Short‑term incentives are likely driven by organic census growth, senior living pricing/occupancy, and near‑term margin improvement, while long‑term equity awards probably emphasize successful integration of acquisitions, sustained quality scores (CMS ratings) and total shareholder return. The payroll‑heavy cost structure and liquidity constraints (recent $118M equity raise, $250M revolver) make cash conservation a likely factor—expect a mix favoring equity or performance‑based awards over large cash payouts, and explicit clawbacks or forfeiture provisions tied to regulatory/audit findings. Local cluster leaders may have compensation plans tied to local operating metrics (census, local margins), while corporate leadership’s incentives will focus on consolidated adjusted EBITDA/EBITDAR and covenant compliance.
Material drivers for insider trading activity at a Healthcare / Medical Care Facilities company like Pennant include regulatory rule changes (CMS payment rules, hospice cap updates), quarterly operational cadence (admissions, occupancy, revenue per unit), and acquisition announcements or integration updates that change forward earnings visibility. Because management uses non‑GAAP measures to evaluate performance and value acquisitions, option grants and performance awards tied to those measures can create predictable vesting events and potential trading around targets—watch for sales after equity raises or option exercises. Regulatory and enforcement risk (Medicare/Medicaid audits, hospice cap exposure, fraud-and-abuse scrutiny) creates frequent blackout/window timing for insiders and increases the importance of 10b5‑1 plans; investors should monitor Form 4 filings for patterns around CMS rule publication dates, earnings releases, and major acquisition closings.